News

Levi & Korsinsky to Represent Investors in C3.ai, Inc. Class Action

Levi & Korsinsky to Represent Investors in C3.ai, Inc. Class Action

Join the C3.ai, Inc. Class Action Lawsuit

C3.ai, Inc., a leading company in the AI space, is currently facing a class action lawsuit related to alleged securities fraud. The legal firm Levi & Korsinsky, LLP is actively notifying affected investors about their rights and the steps they can take in this ongoing legal matter.

Understanding the Class Action Update

The lawsuit aims to recover losses incurred by investors during a specific time frame when C3.ai's stock experienced notable volatility. It covers the period from February 26, 2025, to August 8, 2025. During this time, significant statements were issued by the company that ultimately misled investors about its performance.

Why Are Investors Concerned?

The complaint alleges that C3.ai's leadership provided overly optimistic statements regarding the company’s growth. However, these declarations were shadowed by undisclosed adverse facts. Notably, concerns about the health of their Chief Executive Officer were mentioned as affecting contract closures and profit margins, which were not disclosed adequately.

The Impact on Stock Prices

On August 8, 2025, C3.ai announced disappointing preliminary financial results for the first quarter of its fiscal year, further lowering revenue projections for the entire year. With this announcement, the stock price precipitously fell from $22.13 to $16.47 within just a few days — a staggering drop of roughly 25.58% in a single trading day. Investors felt the repercussions of these unanticipated shifts in stock value.

Steps for Affected Investors

If you held shares in C3.ai during the period in question and experienced financial loss, there are necessary actions you can take. According to Levi & Korsinsky, you have until a specific deadline to request to be appointed as a lead plaintiff in the case. Importantly, participating in this process does not require you to serve as lead plaintiff to benefit from any potential compensation.

No Fees to Participate

One of the most noteworthy aspects of joining this class action is that there are no upfront costs to you as an investor. Class members may be eligible for compensation, and there are no legal fees to worry about when participating in this lawsuit.

Why Choose Levi & Korsinsky?

Levi & Korsinsky has a remarkable history of recovering funds for aggrieved investors. With two decades of experience, the firm has successfully handled complex securities litigation cases. Their track record includes securing hundreds of millions of dollars for shareholders. Their dedicated team of over 70 professionals is committed to protecting investor interests and ensuring just compensation.

Contact Information for Investors

Investors wishing to learn more about their rights and the ongoing class action lawsuit should reach out directly:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
Tel: (212) 363-7500
Email: jlevi@levikorsinsky.com

Frequently Asked Questions

What is the current status of the C3.ai class action?

The class action lawsuit is active, and investors can still join the lawsuit by contacting Levi & Korsinsky for guidance.

What are the alleged issues in this case?

The allegations center on securities fraud and the failure to disclose important information about the company’s financial health and leadership situation.

How can I join the class action if I lost money on my investments?

You need to contact Levi & Korsinsky before the deadline to express your wish to be included in the lawsuit.

Do I have to pay any fees if I join?

No, there are no out-of-pocket fees for participating in this class action lawsuit. You may receive compensation if the lawsuit is successful.

Why should I choose Levi & Korsinsky?

Levi & Korsinsky has extensive experience in securities litigation and a proven track record of successfully advocating for shareholders.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 4

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 5

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 3

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 7

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 5

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 7

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 4

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 5

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading

Top 5 Most Recently Viewed Articles

Discovering Opportunities: North Dakota's Workforce Initiative

Updated Category News Views 172

Welcome to New Beginnings in North Dakota As the season of relocation kicks off, North Dakota is inviting jobseekers with its innovative campaign, Find the Good Life in North Dakota. This initiative coincides with National Moving Day, marking the start of a bustling season when many families seek new horizons across the country. Embrace New Opportunities "People are on...

Continue Reading
Caseware Innovations Garner Multiple Industry Accolades

Updated Category News Views 190

Celebrating Industry Recognition Caseware™, a pioneer in AI-enabled audit, financial reporting, and data analytics, has recently basked in a wave of industry accolades. These recognitions underscore the company's unmatched leadership in driving innovation and delivering impactful solutions to accounting professionals worldwide. A Double Triumph for Caseware In a...

Continue Reading
Telomir Pharmaceuticals' 31% Surge and Pre-market Movers

Updated Category News Views 181

Telomir Pharmaceuticals Sees Significant Pre-market Surge Shares of Telomir Pharmaceuticals Inc (NASDAQ: TELO) experienced a remarkable increase of 31%, reaching $1.86 in pre-market trading. This boost comes in the wake of encouraging preclinical results regarding their primary compound, Telomir-1. Promising Preclinical Study Results The biotechnology firm disclosed these...

Continue Reading
Tech Stocks Likely to Experience Significant Rebound Soon

Updated Category News Views 297

Market Overview for Potential Rebounds The stock market is often unpredictable, with certain stocks experiencing declines even after positive earnings reports. In recent times, some stocks have evidently fallen out of favor with investors, particularly following disappointing earnings or cautious guidance from companies. Interestingly, stocks with low expectations can...

Continue Reading
Acer Inc. Reports Impressive Q3 Performance with 36.1% Growth

Updated Category News Views 72

Acer Inc. Demonstrates Strong Quarter Over Quarter Growth Acer Inc. (TWSE: 2353) has recently shared impressive financial results for the third quarter of 2024, showcasing resilience and growth in a competitive market. The company reported consolidated revenues of NT$72.69 billion, reflecting an 8.3% increase compared to the previous quarter and a 7.8% rise year-on-year....

Continue Reading